These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7912978)

  • 1. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx.
    Otsu M; Hayashi Y; Amatsu M; Itoh H
    Kobe J Med Sci; 1994 Dec; 40(5-6):139-53. PubMed ID: 7616733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.
    Hayashi Y; Ishii N; Obayashi C; Jinnai K; Hanioka K; Imai Y; Itoh H
    Virchows Arch; 1995; 426(1):43-50. PubMed ID: 7704323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
    Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
    J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
    Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
    Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
    Porebska I; Harlozińska A; Bojarowski T
    Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours.
    Yukawa M; Fujimori T; Maeda S; Tabuchi M; Nagasako K
    Gut; 1994 Sep; 35(9):1258-61. PubMed ID: 7959233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
    Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
    Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
    Darmon E; Cleary KR; Wargovich MJ
    Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas.
    Hosaka S; Aoki Y; Akamatsu T; Nakamura N; Hosaka N; Kiyosawa K
    Cancer; 2002 Jan; 94(1):219-27. PubMed ID: 11815980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p185 and p53 in benign and malignant colorectal lesions.
    Porcelli B; Frosi B; Terzuoli L; Arezzini L; Marinello E; Vernillo R; De Martino A; Vatti R; Minacci C
    Histochem J; 2001 Jan; 33(1):51-7. PubMed ID: 11352401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas.
    Kim YW; Huh SH; Park YK; Yoon TY; Lee SM; Hong SH
    Oncol Rep; 2001; 8(5):1127-32. PubMed ID: 11496329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of p53 nuclear oncoprotein in colorectal adenomas.
    Pignatelli M; Stamp GW; Kafiri G; Lane D; Bodmer WF
    Int J Cancer; 1992 Mar; 50(5):683-8. PubMed ID: 1347513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p53 protein and proliferative activity in colorectal adenoma.
    Yamaguchi A; Makimoto K; Goi T; Takeuchi K; Maehara M; Isobe Y; Nakagawara G
    Oncology; 1994; 51(3):224-7. PubMed ID: 7910956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical studies of colorectal cancers that developed following pelvic irradiation.
    Nakao A; Iwagaki H; Yoshino T; Jikuhara A; Kanagawa T; Kimura T; Matsubara N; Isozaki H; Takakura N; Tanaka N
    Surg Today; 2000; 30(2):117-21. PubMed ID: 10664332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.
    Nonomura A; Ohta G; Nakanuma Y; Izumi R; Mizukami Y; Matsubara F; Hayashi M; Watanabe K; Takayanagi N
    Liver; 1988 Jun; 8(3):157-66. PubMed ID: 2839749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.